0.00
price down icon100.00%   -10.15
after-market Handel nachbörslich: 10.17 10.17 +
loading
Schlusskurs vom Vortag:
$10.15
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$448.68M
Einnahmen:
$127.70M
Nettoeinkommen (Verlust:
$-121.25M
KGV:
0.00
EPS:
-3.15
Netto-Cashflow:
$-120.32M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
Value
$0.00
$0.00
1-Wochen-Bereich:
Value
$0.00
$0.00
52-Wochen-Spanne:
Value
$0.00
$11.35

Iteos Therapeutics Inc Stock (ITOS) Company Profile

Name
Firmenname
Iteos Therapeutics Inc
Name
Telefon
857-204-4583
Name
Adresse
321 ARSENAL STREET, WATERTOWN
Name
Mitarbeiter
173
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
ITOS's Discussions on Twitter

Vergleichen Sie ITOS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ITOS
Iteos Therapeutics Inc
0.00 448.68M 127.70M -121.25M -120.32M -3.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
455.48 116.04B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
718.36 75.97B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
458.12 61.48B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
901.17 56.40B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
204.00 43.73B 447.02M -1.18B -906.14M -6.1812

Iteos Therapeutics Inc Stock (ITOS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-28 Herabstufung Wedbush Outperform → Neutral
2025-05-28 Herabstufung Wells Fargo Overweight → Equal Weight
2025-05-14 Herabstufung H.C. Wainwright Buy → Neutral
2025-05-14 Herabstufung Leerink Partners Outperform → Market Perform
2025-05-13 Herabstufung JP Morgan Overweight → Neutral
2024-08-13 Eingeleitet Wells Fargo Overweight
2021-05-05 Eingeleitet H.C. Wainwright Buy
2020-10-08 Eingeleitet Robert W. Baird Outperform
2020-08-18 Eingeleitet JP Morgan Overweight
2020-08-18 Eingeleitet Piper Sandler Overweight
2020-08-18 Eingeleitet SVB Leerink Outperform
2020-08-18 Eingeleitet Wedbush Outperform
Alle ansehen

Iteos Therapeutics Inc Aktie (ITOS) Neueste Nachrichten

pulisher
Dec 04, 2025

Can iTeos Therapeutics Inc. stock deliver surprise earnings beatJuly 2025 Setups & High Yield Equity Trading Tips - Newser

Dec 04, 2025
pulisher
Nov 27, 2025

Why iTeos Therapeutics Inc. stock remains undervalued2025 Trading Recap & Reliable Price Breakout Signals - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 26, 2025

Is KCD Industries India Limited One of the Top Picks for Growth Investors in YEARCandlestick Pattern Analysis & Consistent High Yield Stocks - earlytimes.in

Nov 26, 2025
pulisher
Nov 26, 2025

Can Marco Cables Conductors Limited Generate Insider Confidence Through Shareholder ReturnsPrice Momentum Alerts & Free Realize Exceptional Returns - earlytimes.in

Nov 26, 2025
pulisher
Nov 23, 2025

iTeos Therapeutics Inc Stock Analysis and ForecastBull Market Opportunities & Affordable Trading Growth - earlytimes.in

Nov 23, 2025
pulisher
Nov 20, 2025

Is iTeos Therapeutics Inc. stock a dividend growth opportunityGap Down & Safe Entry Point Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will iTeos Therapeutics Inc. stock sustain high P E ratiosJobs Report & Community Consensus Trade Signals - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will iTeos Therapeutics Inc. stock benefit from commodity pricesJuly 2025 Price Swings & Expert Verified Movement Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will iTeos Therapeutics Inc. price bounce be sustainableWeekly Trading Summary & Daily Profit Focused Stock Screening - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will iTeos Therapeutics Inc. see short term momentum2025 Market Outlook & Safe Entry Momentum Stock Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Using RSI to spot recovery in iTeos Therapeutics Inc.Market Activity Recap & Precise Entry and Exit Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can iTeos Therapeutics Inc. stock sustain free cash flow growth - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will iTeos Therapeutics Inc. stock continue upward momentumTrade Performance Summary & Weekly Watchlist of Top Performers - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can iTeos Therapeutics Inc. stock maintain growth trajectory2025 Momentum Check & Stock Portfolio Risk Management - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Predicting iTeos Therapeutics Inc. trend using moving averagesWeekly Trade Analysis & Risk Controlled Swing Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Forecasting iTeos Therapeutics Inc. price range with options dataTrade Volume Report & Smart Allocation Stock Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Technical signs of recovery in iTeos Therapeutics Inc.2025 Momentum Check & Daily Price Action Insights - newser.com

Nov 19, 2025
pulisher
Nov 17, 2025

How sustainable is iTeos Therapeutics Inc. stock dividend payoutQuarterly Risk Review & Expert Curated Trade Setup Alerts - newser.com

Nov 17, 2025
pulisher
Nov 16, 2025

Is a relief rally coming for iTeos Therapeutics Inc. holders2025 Institutional Moves & Consistent Profit Trade Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Is iTeos Therapeutics Inc. forming a bottoming baseJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com

Nov 16, 2025
pulisher
Nov 14, 2025

Applying big data sentiment scoring on iTeos Therapeutics Inc.Earnings Summary Report & Capital Efficient Trading Techniques - newser.com

Nov 14, 2025

Finanzdaten der Iteos Therapeutics Inc-Aktie (ITOS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$39.73
price up icon 1.44%
$31.74
price down icon 0.91%
$102.52
price up icon 2.03%
$96.25
price up icon 0.27%
biotechnology ONC
$322.90
price down icon 2.53%
$204.00
price down icon 0.51%
Kapitalisierung:     |  Volumen (24h):